Coquitlam
Canada
42
2025-07-03
The entities that hold a legal rights for patent applications filed by inventor Sun Shaoyi:
Shaoyi Sun from Coquitlam, CA has applied for patents for these inventions. The list has both pending applications and granted patents:
PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS
#2 | 2025-02-20PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS
#3 | 2023-06-29PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS
#4 | 2023-05-11Pyridine derivatives and their use as sodium channel activators
#5 | 2022-11-03Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
#6 | 2020-05-21Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
#7 | 2017-04-27SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
#8 | 2017-03-09ASYMMETRIC SYNTHESES FOR SPIRO-OXINDOLE COMPOUNDS USEFUL AS THERAPEUTIC AGENTS
#9 | 2016-10-06ORGANIC COMPOUNDS
#10 | 2015-10-15Spiro-oxindole compounds and their use as therapeutic agents
#11 | 2014-01-23ORGANIC COMPOUNDS
#12 | 2013-10-17Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
#13 | 2013-09-26Spiro-oxindole compounds and their use as therapeutic agents
#14 | 2013-04-18AMINOTHIAZOLE DERIVATIVES AS HUMAN STEAROYL-COA DESATURASE INHIBITORS
#15 | 2013-01-10PYRAZOLE DERIVATIVES WHICH MODULATE STEAROYL-COA DESATURASE
#16 | 2012-11-22Spiro-oxindole compounds and their uses as therapeutic agents
#17 | 2012-01-19Organic compounds
#18 | 2012-01-05Organic compounds
#19 | 2011-11-03SPIRO-OXINDOLE-DERIVATIVES AS SODIUM CHANNEL BLOCKERS
#20 | 2011-07-14Use of spiro-oxindole compounds as therapeutic agents
#21 | 2011-05-12SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
#22 | 2011-01-13HETEROCYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
#23 | 2010-09-16Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels
#24 | 2010-07-08USE OF SPIRO-OXINDOLE COMPOUNDS AS THERAPEUTIC AGENTS
#25 | 2010-06-17Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
#26 | 2010-06-03Spiro-oxindole compounds and their use as therapeutic agents
#27 | 2010-05-20Spiro-oxindole compounds and their uses as therapeutic agents
#28 | 2010-04-22Spiro-oxindole compounds and their use as therapeutic agents
#29 | 2010-02-04SCD1 inhibitors triazole and tetrazole compounds
#30 | 2010-02-04Heterocyclic inhibitors of stearoyl-CoA desaturase
#31 | 2009-12-10Substituted pyridazines as stearoyl-CoA desaturase inhibitors
#32 | 2009-11-26HETEROCYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
#33 | 2009-10-22Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymes
#34 | 2009-08-06NICOTINAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
#35 | 2009-06-18Organic compounds
#36 | 2008-05-29Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
#37 | 2008-05-08Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
#38 | 2008-04-24Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
#39 | 2007-12-27Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
#40 | 2007-09-20Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)
#41 | 2007-05-10Oxindole compounds and their uses as therapeutic agents
#42 | 2006-11-09Spiro-oxindole compounds and their uses as therapeutic agents
26901 ⎘